5004592026-04-012026-06-305004592026-04-012026-06-30in-capmkt:OtherExpenses1Member5004592026-04-012026-06-30in-capmkt:OtherExpenses2Member5004592026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares500459PGHHNOTLISTEDINE179A01014Procter & Gamble Hygiene and Health Care LimitedMain BoardEquity2026-04-012027-03-312026-07-292026-06-26INRLakhsQuarterlyFirst quarterSingle segmentHygiene and Health Care2026-07-2911:56:002026-07-2912:45:00Not applicablefalsefalseNot Applicable2026-04-012026-06-30UnauditedStandalone891460000094300000900890000020024000002132300000-33220000054360000027000009590000028679000007312600000169630000001696300000438900000-530000043360000001262700000000012627000001070000012734000003246000001038.938.90038.938.91. The above Unaudited Financial Results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on 29th July, 2026 and have been subjected to a limited review by the Statutory Auditors of the Company. These financial results are prepared and published in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. <br /> 2. The Unaudited Financial Results are prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 “Interim Financial Reporting” (Ind AS-34), as prescribed under Section 133 of the Companies Act, 2013, read with relevant Rules issued thereunder and other accounting principles generally accepted in India. <br /> 3. The Company's operating segments under Ind AS 108 – Operating Segments are as follows: <br /> - Health Care Products – Comprising of Ointment and Creams, Cough Drops and Tablets. <br /> - Hygiene Products - Comprising of Feminine Hygiene products and other skin care hygiene. <br /> These individual operating segments have been aggregated into a single primary reportable segment i.e. manufacturing, trading and marketing of Health and Hygiene Products in accordance with Ind AS 108-Operating Segments. Accordingly, no separate segment information has been provided. <br /> 4. The Company does not have a subsidiary, associate or a joint venture as at June 30, 2026. <br /> 5. The figures of the preceding three months ended March 31, 2026, are the balancing figures between audited figures in respect of the full financial year ended March 31, 2026, and the published year to date figures up to the third quarter of that financial year. <br /> Advertising & sales promotion expenses833200000Other expenses2034700000Re- measurement of defined benefit plans14300000143000003600000010700000